Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Decreased circulating miRNA levels in patients with primary progressive multiple sclerosis.
A Novel Bmal1 Mutant Mouse Reveals Essential Roles of the C-Terminal Domain on Circadian Rhythms.
RNA-sequencing reveals oligodendrocyte and neuronal transcripts in microglia relevant to central nervous system disease.
Subcortical brain segmentation of two dimensional T1-weighted data sets with FMRIB's Integrated Registration and Segmentation Tool (FIRST).
Exercise in the management of persons with multiple sclerosis.
CX3CR1 in multiple sclerosis.
Computer-Assisted Cognitive Rehabilitation of Attention Deficits for Multiple Sclerosis: A Randomized Trial With fMRI Correlates.
[Clinical significance of the cardiovascular effects of fingolimod treatment in multiple sclerosis].
The Immune Pathogenesis of Multiple Sclerosis.
Correction: Comparative Study on the Therapeutic Potential of Neurally Differentiated Stem Cells in a Mouse Model of Multiple Sclerosis.
Biomarkers in multiple sclerosis: an update for 2014.
Environmental factors and multiple sclerosis severity: a descriptive study.
Antineutrophil Cytoplasmic Antibodies in Patients with Idiopathic Inflammatory-Demyelinating Diseases.
Chromatic visual evoked potentials in young patients with demyelinating disease.
Increasing serum levels of vitamin A, D and E are associated with alterations of different inflammation markers in patients with multiple sclerosis.
Extracellular Vesicles in Multiple Sclerosis: What are They Telling Us?
Gender and Uveitis in Patients with Multiple Sclerosis.
Antibody index test may aid PML diagnosis on natalizumab
Multiple sclerosis: Brain volume loss strengthens disease measure.
The impact of slower walking speed on activities of daily living in patients with multiple sclerosis.
Lower urinary tract symptoms of neurological origin in urological practice.
Inflammatory cytokines at the summits of pathological signal cascades in brain diseases.
Myelin repair and functional recovery mediated by neural cell transplantation in a mouse model of multiple sclerosis.
Sex-specific environmental influences affecting MS development.
Characteristic cerebrospinal fluid cytokine/chemokine profiles in neuromyelitis optica, relapsing remitting or primary progressive multiple sclerosis.
Pages
« first
‹ previous
…
355
356
357
358
359
360
361
362
363
…
next ›
last »